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Background: To determine the prevalence and clinicopathologic features of the oral cancer patients.
Material and Methods: Biopsy records of the participating institutions were reviewed for oral cancer cases di-
agnosed from 2005 to 2014. Demographic data and site of the lesions were collected. Sites of the lesion were 
subdivided into lip, tongue, floor of the mouth, gingiva, alveolar mucosa, palate, buccal/labial mucosa, maxilla 
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Introduction
Oral cancer is the sixth most common malignancy 
worldwide (1). Three hundred thousand patients (2.1% 
of the total cancer cases) were afflicted with cancer of 
the oral cavity and lip in 2012. One hundred and forty 
five thousand patients passed away from cancer of the 
oral cavity and lip (2).
It has long been accepted that tobacco consumption in-
cluding smokeless tobacco and heavy alcohol consump-
tion are the principal etiologic factors for the develop-
ment of oral cancer.  In addition, a variety of suspected 
risk factors such as chronic irritation, poor oral hygiene, 
viral infection, occupational exposure, malnutrition as 
well as low fruit and vegetable diets, and genetic factors, 
have been proposed for the development of oral cancer 
(3,4). The most important risk factors for squamous cell 
carcinoma are tobacco use and alcohol abuse, which 
have synergistic effect (5-7). Cigarette smoke contains 
more than 60 carcinogens according to the International 
Agency for Research on Cancer (8). Tobacco-specific 
N-nitrosamines, especially 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) and N’-nitrosonornicotine 
(NNN), have been demonstrated to cause cancer in exper-
imental animals.  NNK is metabolically activated by cyto-
chromes P450 to DNA-reactive metabolites which induce 
methylation as well as pyridyloxobutylation of nucleobases 
in DNA and form DNA adducts.  For NNN, the 2’- and 
5’-α-hydroxylation pathways are the major pathways lead-
ing to the formation of DNA adducts.  The resulting DNA 
adducts may induce deleterious mutations in oncogenes 
and tumor suppressor genes which could be considered as 
tumor initiation (9,10). In the Indian subcontinent, some 
parts of Southeast Asia, and Taiwan, the use of betel quids 
containing areca nut and lime has long been strongly as-
sociated with an increased risk for oral cancer. 
Previous studies have shown that alcohol consumption is 
an independent risk factor for the development of cancer 
in the dose dependent manner (11). Alcohol is first oxi-
dized to acetaldehyde by alcohol dehydrogenase (ADH). 
Acetaldehyde is considered to be a group I carcinogen 
according to the International Agency for Research on 
Cancer (IARC). Acetaldehyde is further metabolized 
to acetate by aldehyde dehydrogenase (ALDH). Any 
defect in these enzymes (ADH and ALDH) may influ-
ence the carcinogenesis by alcohol (12). Alcohol also in-
duces basal cell proliferation and generates free radicals 
which have the deleterious effects on DNA.  In addition, 
alcohol-associated impairment of the body’s ability to 
breakdown and absorb nutrients and immune suppres-
sion may further promote carcinogenesis (6,7).
Apart from tobacco use and alcohol abuse, human pap-
illoma virus has recently received special attention. 
Human papilloma virus, HPV-16 in particular, has been 
indicated as an etiological agent for the development of 
a subset of squamous cell carcinoma, especially at the 
base of the tongue and the tonsillar area in the younger 
individuals compared to the HPV-negative counterpart 
(13,14). The proportion of HPV-positive oropharyngeal 
cancer was 56% in North America, 52% in Japan, 45% 
in Australia, 39% in Northern and Western Europe, 
38% in Eastern Europe, 17% in Southern Europe and 
13% in the rest of the world (15).
There is a wide variation in the prevalence of oral can-
cer in different regions of the world or even within the 
same countries from the minorities or sub-populations. 
The aims of this research were to report the prevalence 
as well as clinicopathologic features of the oral cancer 
patients from different parts of Asia and Canada and 
to compare them with patients from other parts of the 
world.
and mandible.  Oral cancer was subdivided into 7 categories: epithelial tumors, salivary gland tumors, hematologic 
tumors, bone tumors, mesenchymal tumors, odontogenic tumors, and others. Data were analyzed by descriptive 
statistics using SPSS software version 17.0.
Results: Of the 474,851 accessioned cases, 6,151 cases (1.30%) were diagnosed in the category of oral cancer. The 
mean age of the patients was 58.37±15.77 years. A total of 4,238 cases (68.90%) were diagnosed in males, whereas 
1911 cases (31.07%) were diagnosed in females. The male-to-female ratio was 2.22:1. The sites of predilection for 
oral cancer were tongue, labial/buccal mucosa, gingiva, palate, and alveolar mucosa, respectively. The three most 
common oral cancer in the descending order of frequency were squamous cell carcinoma, non-Hodgkin lymphoma 
and mucoepidermoid carcinoma.
Conclusions: Although the prevalence of oral cancer is not high compared to other entities, oral cancer pose signifi-
cant mortality and morbidity in the patients, especially when discovered late in the course of the disease.  This study 
highlights some anatomical locations where oral cancers are frequently encountered.  As a result, clinicians should 
pay attention to not only teeth, but oral mucosa especially in the high prevalence area as well since early detection of 
precancerous lesions or cancers in the early stage increase the chance of patient being cured and greatly reduce the 
mortality and morbidity.  This study also shows some differences between pediatric and elderly oral cancer patients 
as well as between Asian and non-Asian oral cancer patients.
Key words: Oral cancer, prevalence, clinic-pathologic features, retrospective study.
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Material and Methods
The biopsy records of the Department of Oral Pathol-
ogy, Chulalongkorn University, Gangneung-Wonju Na-
tional University and Kyungpook National University, 
Department of Oral Biology and Diagnostic Sciences, 
Chiangmai University, Department of Oral Diagnosis, 
Khon Kaen University, Department of Stomatology, 
Prince of Songkla University, Department of Oral and 
Maxillofacial Pathology, Tehran University of Medi-
cal Sciences, Department of Pathology and Laboratory 
Medicine, Western University and Department of Oral 
Pathology and Oral Diagnosis, School of Dentistry, Na-
tional Taiwan University were reviewed for oral cancer 
cases diagnosed from 2005 to 2014.  Demographic data 
and site of the lesion were also collected. Sites of the le-
sion were subdivided into lip, tongue, floor of the mouth, 
gingiva, alveolar mucosa, palate, buccal/labial mucosa, 
maxilla and mandible. Oral cancer was subdivided into 
7 categories: epithelial tumors, salivary gland tumors, 
hematologic tumors, bone tumors, mesenchymal tu-
mors, odontogenic tumors, and others. Data collected 
Table 1: Prevalence, average age and M:F ratio of oral cancer patients.
were analyzed by appropriate statistics using SPSS Sta-
tistics for Windows, Version 17.0. Chicago: SPSS Inc. A 
P value less than .05 was considered to be statistically 
significant. This research was approved by the ethical 
committee of the Faculty of Dentistry, Chulalongkorn 
University (no. 90/2015).
Results
Of the 474,851 accessioned cases, 6,151 cases (1.30%) 
were diagnosed in the category of oral cancer. The 
prevalence of oral cancer ranged from 0.83% in Tai-
wan to 6.23% in Thailand (Table 1). The age of the pa-
tients in the present study ranged from 3 to 111 years 
with a mean ± SD = 58.37±15.77 years. The majority of 
the cases (81.26%) were encountered in the fifth to the 
eighth decades of life.  Sixty seven cases (1.09%) were 
discovered in children aged 16 and below. Two thousand 
one hundred and forty eight cases (34.92%) were found 
in the elderly (aged 65 and above) (Fig. 1). Mean age 
of the pediatric patients±SD was 5.81±6.07, while that 
of the elderly patients was 75.0±7.74. Mean age of the 
Fig. 1: Age distribution of oral cancer patients.
Table 1   Prevalence, average age and M:F ratio of oral cancer patients 
Country Prevalence Mean age±SD M:F ratio 
Canada 1.71 69.22±15.51 1.28:1 
Korea 3.43 61.41±14.36 1.67:1 
Iran 3.88 56.55±19.80 1.13:1 
Taiwan 0.83 54.83±12.34 5.62:1 
Thailand 6.23 59.13±17.32 0.86:1 
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Asian patients±SD was 56.37±14.98 years, while that 
of the non-Asian patients was 69.99±15.51 years. Mean 
age of the Asian patients was significantly lower than 
that of the non-Asian patients (p=0.000). Most coun-
tries demonstrated a male predilection except Thailand. 
The male-to-female ratio was 2.22:1. It was noteworthy 
that the male-to-female ratio from Taiwan was as high 
as 5.62:1 (Table 1). Both the pediatric and elderly oral 
cancer patients elicited a slight male predilection with 
the male-to-female ratio of 1.31:1 and 1.28:1, respec-
tively.
Regarding the anatomical distribution of oral cancer, 
the 5 most common sites for oral cancer in descend-
ing order of frequency were tongue (25.4%), labial/
buccal mucosa (21.7%), gingiva (14.0%), palate (9.9%), 
and alveolar mucosa (7.9%), respectively. Labial/buccal 
mucosa was the most common site for oral cancer in 
Taiwan, while tongue was the site of predilection for 
oral cancer in Canada and Iran and gingiva for Korea 
and Thailand. In children aged 16 and below, the 5 most 
common sites for oral cancer in descending order of fre-
quency were mandible (17.9%), palate (14.9%), gingiva 
(13.4%), alveolar mucosa (11.9%), maxilla and tongue 
(10.4% each), respectively. In the elderly aged 65 and 
above, the 5 most common sites for oral cancer in de-
scending order of frequency were tongue (20.8%), la-
bial/buccal mucosa (18.2%), gingiva (16.0%), alveolar 
mucosa (14.5%), and palate (9.5%), respectively.  Tongue 
was the site of predilection of oral cancer for both Asian 
and non-Asian patients. The second most common site 
for oral cancer in the Asian patients was labial/buccal 
mucosa, followed by gingiva and palate, respectively, 
while the second most common site for oral cancer in 
the non-Asian patients was alveolar mucosa followed by 
floor of the mouth and lip, respectively.
Most of the oral cancer (5,234 cases, 85.09%) fell in the 
epithelial tumor category followed by salivary gland 
tumor category (411 cases, 6.68%), hematologic tumor 
category (275 cases, 4.47%), bone tumor category (81 
cases, 1.32%), mesenchymal tumor category (73 cases, 
1.19%), others category (57 cases, 0.93%), and odonto-
genic tumor category (20 cases, 0.33%), respectively 
(Table 2, 2 continue). Epithelial tumor category ranked 
as the most common oral cancer category in all coun-
tries, while salivary gland tumor category came second 
in almost all countries except Canada and the third most 
Table 2: Histopathologic diagnosis of oral cancer patients.
 
Table 2 Histopathologic diagnosis of oral cancer 
Tumors Canada Iran South 
Korea 
Taiwan Thailand Total number 
(Percent of all 
cancer cases) 
Epithelial tumors 768 146 343 2941 1036 5234 (85.09%) 
  Squamous cell carcinoma 711 132 327 2790 964 4924 (80.05%) 
  Verrucous carcinoma 35 5 9 123 38 210 (3.41%) 
  Metastatic carcinoma 13 1 5 16 23 58 (0.94%) 
  Undifferentiated carcinoma 6 6 0 6 6 24 (0.39%) 
  Others 3 2 2 6 5 18 (0.29%) 
Salivary gland tumors 95 16 51 91 158 411 (6.68%) 
  Mucoepidermoid carcinoma 36 6 22 37 85 186 (3.02%) 
  Adenoid cystic carcinoma 21 5 18 25 48 117 (1.90%) 
  Polymorphous low-grade     
     adenocarcinoma 
18 0 3 7 6 34 (0.55%) 
  Adenocarcinoma NOS 6 2 4 9 11 32 (0.52%) 
  Carcinoma ex pleomorphic  
     adenoma 
2 2 0 2 3 9 (0.15%) 
  Others 12 1 4 11 5 33 (0.54%) 
Hematologic tumors 74 3 24 57 117 275 (4.47%) 
  Lymphoma 66 3 22 47 101 239 (3.89%) 
  Myeloma 8 0 2 6 14 30 (0.49%) 
  Leukemia 0 0 0 1 2 3 (0.05%) 
  Myeloid sarcoma 
Bone tumors   
  Osteosarcoma 
  Chondrosarcoma 
  Ewing’s sarcoma                                       
0 
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common oral cancer category in most countries was he-
matologic tumor category except Canada. In Canada, 
the second most common oral cancer category was he-
matologic tumor category followed by salivary gland 
tumor category. The most common oral cancer was 
squamous cell carcinoma which constituted 94.08% 
of all epithelial tumors and 80.05% of all oral cancer 
cases. The second most prevalent oral cancer was lym-
phoma which accounted for 86.91% of the hematologic 
tumors and 3.89% of all oral cancer cases. The third 
most prevalent oral cancer was mucoepidermoid car-
cinoma which constituted 45.26% of all salivary gland 
tumors and 3.02% of all oral cancer cases.  In the pedi-
atric patients, squamous cell carcinoma was the most 
common tumor constituting 40.29% of the cases in 
this group, followed by mucoepidermoid carcinoma 
(16.42%) and lymphoma (14.93%), respectively.  In the 
elderly patients, squamous cell carcinoma was the most 
prevalent tumor constituting 80.77% of the cases in 
this group, followed by verrucous carcinoma (5.42%), 
and lymphoma (5.21%), respectively. Squamous cell 
carcinoma was the most common oral cancer in both 
Asian (80.23%) and non-Asian patients (73.46%). The 
second most common oral cancer in Asian patients was 
verrucous carcinoma (3.37%) followed by lymphoma 
Table 2 continue: Histopathologic diagnosis of oral cancer patients.
(3.33%), mucoepidermoid carcinoma (2.89%) and ad-
enoid cystic carcinoma (1.85%), respectively, while the 
second most common oral cancer in non-Asian patients 
was lymphoma(6.90%) followed by mucoepidermoid 
carcinoma (3.76%), verrucous carcinoma (3.66%) and 
adenoid cystic carcinoma (2.19%), respectively. Thus 
the entities constituting the top five most common oral 
cancers for both Asian and non-Asian patients were ex-
actly the same, but with different ranking.
There were 58 cases of metastatic tumors to the oral 
cavity which constituted 0.94% of the oral cancer. 
Mean age of the patients±SD was 61.31±16.23 years. 
Male-to-female ratio was 1.52:1. The sites of predilec-
tion for metastatic tumors were the mandible followed 
by the gingiva.  Several sites such as lung, thyroid gland, 
breast, kidney liver, colon, pancreas, bile duct were the 
primary sites for the metastatic tumors to the oral cav-
ity in the present study, but the most common ones were 
the thyroid gland and the lung.
Discussion
The prevalence of oral cancer from the present study 
was 1.30% which was comparable to the prevalence of 
0.15% from Australia (16), but lower than the preva-
lence of 6.23% from Thailand (17), 8.0% and 8.2% from 
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Libya (18,19) 14.82% from UAE (20), 18.0% from Nige-
ria (21) and 24.8% from Zimbabwe (22). The disparity 
in the prevalence might be attributable to the difference 
in the distribution of risk factors in each geographical 
area (20,21). The mean age of the patients with oral can-
cer in this study was 58.37 years which is comparable 
to the findings in UAE (54.9 years) (20), Thailand (59.13 
years) (17), Iran (61.2 years) (23), Malaysia (61.2 years) 
(24), Jordan (62.5 years) (25) and Japan (65.2 years) 
(26), but higher than the findings in Nigeria (42.2 years) 
(21), Libya (46.0 years) (18,19), and India (47.8 and 49.7 
years) (27,28). Many more patients with oral cancer 
from this study were male with the male-to-female ratio 
of 2.22:1 which was in accordance with most previous 
reports which consistently showed a male predominance 
(18,19,22,23,25,26,29-32), but contrary to the Malaysian 
study which demonstrated the male-to-female ratio of 
0.92:1 (24). Previous study of oral cancer from Thai-
land also reported more female than male patients as in 
the present study (17,33). As Malaysia and Thailand are 
neibouring countries, residents are exposed to similar 
type of environment and share some cultural practices, 
so both countries elicit a female predilection.  In addi-
tion, more female patients seek medical attention than 
male patients in Thailand.
Most of the oral cancer in the present study were en-
countered at the tongue which was in accordance with 
most previous reports (20,23,26,30,32,34). The reasons 
why the tongue and the cheek are the predilection sites 
for oral cancer are that the carcinogens in the oral cavity 
mixing with saliva have the tendency to pool at the bot-
tom of the mouth and these sites are covered by thin and 
non-keratinized mucosa. As a consequence, they pro-
vide less protection against the carcinogen (35). How-
ever, Chidzonza (22) reported that gingiva was the most 
common site for oral cancer followed by the tongue. 
Khan et al. (24) revealed that oral mucosa was the most 
common site for oral cancer followed by the tongue. 
Howell et al. (29) reported that the site of predilection 
for oral cancer was the lip followed by the tongue. The 
explanation for the high incidence of lip cancer is due to 
the overexposure to ultraviolet light, especially in Aus-
tralia where residents have fair complexion. One study 
from India demonstrated that mandibular alveolus was 
the frequently involved site, followed by buccal muco-
sa. This is accounted for by the practice of betel quid/
tobacco chewing (28). As a consequence, the alveolar 
mucosa, gingiva and buccal mucosa are constantly in 
contact with the carcinogens for a long period of time. 
This also explains the labial/buccal mucosa and gingiva 
as sites of predilection of oral cancer for Taiwan and 
Thailand among betel nut chewers.
Epithelial tumor category constituted the largest category 
of all the oral cancer followed by the salivary gland tumor 
category. This finding is in accordance with previous stud-
ies (18-24,32). Nonetheless, the studies by Ajayi et al. (21) 
and Rawashdeh & Matalka (25) revealed that sarcoma was 
the second most common category.  Within the epithelial 
tumor category, squamous cell carcinoma was the most 
common tumor and the most common oral cancer as in 
previous studies (18-29,31,32). Within the salivary gland 
tumor category, the most prevalent tumor was mucoepi-
dermoid carcinoma. Mucoepidermoid carcinoma was 
consistently ranked as the most common intraoral salivary 
gland tumor (19,20,24). However, some studies showed 
that adenoid cystic carcinoma was the most prevalent in-
traoral malignant salivary gland tumor (21,23).
In the present study, squamous cell carcinoma account-
ed for 80.05% of all oral cancer.  This figure is lower 
than several previous studies which have reported that 
squamous cell carcinoma accounts for from 84.40% to 
90% of all oral cancer (23-5,29,32,36). However, lower 
figures (63.00% to 73.10%) than the present study have 
been reported (20-22,34).
Conclusions
Although the prevalence of oral cancer is not high 
compared to other entities, oral cancer pose significant 
mortality and morbidity in the patients, especially when 
discovered late in the course of the disease.  This study 
highlights some anatomical locations where oral can-
cers are frequently encountered.  As a result, clinicians 
should pay attention to not only teeth, but oral mucosa 
especially in the high prevalence area as well since early 
detection of precancerous lesions or cancers in the early 
stage increase the chance of patient being cured and 
greatly reduce the mortality and morbidity.  This study 
also shows some differences between pediatric and el-
derly oral cancer patients as well as between Asian and 
non-Asian oral cancer patients.
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